Here is a very recent discussion between some highly regarded individuals within the ophthalmology space regarding the benefits of combining canaloplasty with a stent -- meaning that EYE may not necessarily have to compete with Glaukos and instead, will benefit from the success of iStent
Viscodilation in the Canal - Eyetube
Nova Eye Medical (EYE) Discussion, page-3
-
- There are more pages in this discussion • 3,185 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
24.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $54.91M | |||
| Open | High | Low | Value | Volume |
| 24.0¢ | 24.5¢ | 24.0¢ | $73.06K | 304.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 342553 | 23.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 24.0¢ | 50108 | 1 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| EYE (ASX) Chart |